Works matching IS 1007385X AND DT 2021 AND VI 28 AND IP 9
1
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 947, doi. 10.3872/j.issn.l007-385x.2021.09.013
- Article
2
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 942, doi. 10.3872/jJssn.l007-385x.202L09.012
- Article
3
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 926, doi. 10.3872/jJssn.l007-385x2021.09.010
- Article
4
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 920, doi. 10.3872/j.issn.l007-385x.2021.09.009
- Article
5
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 914, doi. 10.3872/jJssn.l007-385x2021.09.008
- Article
6
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 908, doi. 10.3872/jJssn.l007-385x2021.09.007
- Article
7
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 933, doi. 10.3872/j.issn.l007-385x.2021.09.011
- Article
8
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 900, doi. 10.3872/j.issn.l007-385x.2021.09.006
- Article
9
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 885, doi. 10.3872/j.issn.l007-385x.2021.09.004
- Article
10
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 877, doi. 10.3872/j.issn.l007-385x.2021.09.003
- Article
11
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 869, doi. 10.3872/j.issn.l007-385x.2021.09.002
- Article
12
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 863, doi. 10.3872/j.issn.l007-385x.2021.09.001
- Article
13
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 9, p. 893, doi. 10.3872/j.issn.l007-385x.2021.09.005
- Article